Scientific Reports (Aug 2017)

Duplication events downstream of IRX1 cause North Carolina macular dystrophy at the MCDR3 locus

  • Valentina Cipriani,
  • Raquel S. Silva,
  • Gavin Arno,
  • Nikolas Pontikos,
  • Ambreen Kalhoro,
  • Sandra Valeina,
  • Inna Inashkina,
  • Mareta Audere,
  • Katrina Rutka,
  • Bernard Puech,
  • Michel Michaelides,
  • Veronica van Heyningen,
  • Baiba Lace,
  • Andrew R. Webster,
  • Anthony T. Moore

DOI
https://doi.org/10.1038/s41598-017-06387-6
Journal volume & issue
Vol. 7, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Autosomal dominant North Carolina macular dystrophy (NCMD) is believed to represent a failure of macular development. The disorder has been linked to two loci, MCDR1 (chromosome 6q16) and MCDR3 (chromosome 5p15-p13). Recently, non-coding variants upstream of PRDM13 (MCDR1) and a duplication including IRX1 (MCDR3) have been identified. However, the underlying disease-causing mechanism remains uncertain. Through a combination of sequencing studies on eighteen NCMD families, we report two novel overlapping duplications at the MCDR3 locus, in a gene desert downstream of IRX1 and upstream of ADAMTS16. One duplication of 43 kb was identified in nine families (with evidence for a shared ancestral haplotype), and another one of 45 kb was found in a single family. Three families carry the previously reported V2 variant (MCDR1), while five remain unsolved. The MCDR3 locus is thus refined to a shared region of 39 kb that contains DNAse hypersensitive sites active at a restricted time window during retinal development. Publicly available data confirmed expression of IRX1 and ADAMTS16 in human fetal retina, with IRX1 preferentially expressed in fetal macula. These findings represent a major advance in our understanding of the molecular genetics of NCMD and provide insights into the genetic pathways involved in human macular development.